Literature DB >> 15857166

Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes.

K Genc1, S Genc, H Baskin, I Semin.   

Abstract

In the present study, we investigated whether erythropoietin (Epo) has a protective effect against cytotoxicity induced by interferon-gamma (IFN-gamma ) and lipopolysaccharide (LPS) in primary rat oligodendrocyte cultures. The possible modulatory effect of erythropoietin on inducible nitric oxide synthase (iNOS) mRNA expression and nitrite production were also analyzed. Erythropoietin exerted a significant protective effect against IFN-gamma and LPS-induced oligodendrocyte injury as determined by lactate dehydrogenase assay. Treatment with erythropoietin inhibited the expression of iNOS mRNA and nitrite production resulting from proinflammatory stimulation by IFN-gamma and LPS. These results suggest that erythropoietin has protective effects against inflammatory oligodendrocyte injury in vitro and may play a protective role in neurological disorders characterized by oligodendrocyte death, such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857166     DOI: 10.33549/physiolres.930749

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  20 in total

1.  Outcomes of extremely low birth weight infants given early high-dose erythropoietin.

Authors:  R M McAdams; R J McPherson; D E Mayock; S E Juul
Journal:  J Perinatol       Date:  2012-06-21       Impact factor: 2.521

2.  Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury.

Authors:  Masanori Iwai; R Anne Stetler; Juan Xing; Xiaoming Hu; Yanqin Gao; Wenting Zhang; Jun Chen; Guodong Cao
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

3.  Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.

Authors:  Ilaria Cervellini; Alexander Annenkov; Thomas Brenton; Yuti Chernajovsky; Pietro Ghezzi; Manuela Mengozzi
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

Review 4.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

5.  Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.

Authors:  Christopher M Traudt; Sandra E Juul
Journal:  Methods Mol Biol       Date:  2013

6.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 7.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

8.  Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury.

Authors:  Lauren L Jantzie; Robert H Miller; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2013-09-03       Impact factor: 3.756

Review 9.  [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

Authors:  C Kleinschnitz; S G Meuth; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

Review 10.  Oxidative mechanisms of brain dysfunction during sepsis.

Authors:  Felipe Dal-Pizzol; Cristiane Ritter; Omar J Cassol; Gislaine T Rezin; Fabrícia Petronilho; Alexandra I Zugno; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-08-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.